Lesh M D, Van Hare G F, Fitzpatrick A P, Griffin J C, Chu E
Department of Medicine, University of California, San Francisco 94143.
J Electrocardiol. 1993;26 Suppl:194-203.
Radiofrequency catheter ablation has become the treatment of choice for paroxysmal supraventricular tachycardia involving dual atrioventricular nodes or an accessory pathway. For reentry confined to the atrium where the arrhythmia itself or the ventricular response cannot be controlled with drugs, catheter ablation of the His bundle is a treatment option, but requires implantation of a permanent pacemaker and does not restore normal rhythm. In the atria, important anatomic obstacles, such as the great veins and the ostium of the coronary sinus, interrupt the normal arrangement of myocardial fibers. Under certain circumstances these natural obstacles, or those created during atrial surgery for congenital heart disease, may help to facilitate conditions for reentrant excitation within the atrium. The purpose of this study was to evaluate the safety and efficacy of radiofrequency ablation directed at a protected isthmus of slow conduction in patients with reentrant atrial tachycardia or flutter. Eighteen patients with drug-refractory atrial arrhythmias underwent invasive electrophysiology testing, followed in the same session by ablation using radiofrequency energy delivered between the large distal electrode of a deflectable catheter and a skin patch. In eight patients, intracardiac echocardiographic imaging was performed to compliment fluoroscopy. These 18 patients had a total of 20 atrial tachyarrhythmias: atypical atrial flutter (1 patient), typical atrial flutter (13), intraatrial reentrant tachycardia (5), and sinus node reentry (1). There were 5 women and 13 men with an age range of 8 to 81 years. Structural heart disease was present in 10 of 14 patients with atrial flutter, and 4 patients with intraatrial reentrant tachycardias had surgery for congenital heart disease. Acute success was achieved in 12 of 13 cases (92%) of typical atrial flutter and in 6 of 6 cases of other atrial reentrant tachyarrhythmias, including sinus node reentry and five arrhythmias associated with congenital heart disease surgery. One patient developed a deep venous thrombosis. Radiofrequency catheter ablation, by severing narrow corridors of slow conduction, can safely abolish reentrant atrial arrhythmias in humans. Long-term follow-up evaluation will be required since these patients generally have atrial disease and recurrence of the ablated arrhythmia or the emergence of new arrhythmias is a possibility.
射频导管消融术已成为治疗涉及双房室结或旁路的阵发性室上性心动过速的首选方法。对于局限于心房的折返,若心律失常本身或心室反应无法通过药物控制,希氏束导管消融是一种治疗选择,但需要植入永久性起搏器且不能恢复正常心律。在心房中,重要的解剖学障碍,如大静脉和冠状窦口,会中断心肌纤维的正常排列。在某些情况下,这些天然障碍或先天性心脏病心房手术中造成的障碍,可能有助于促进心房内折返激动的条件。本研究的目的是评估针对折返性房性心动过速或心房扑动患者中受保护的缓慢传导峡部进行射频消融的安全性和有效性。18例药物难治性房性心律失常患者接受了有创电生理检查,随后在同一次检查中使用可弯曲导管的大远端电极与皮肤贴片之间传递的射频能量进行消融。8例患者进行了心腔内超声心动图成像以辅助荧光透视。这18例患者共有20次房性快速心律失常:非典型心房扑动(1例)、典型心房扑动(13例)、房内折返性心动过速(5例)和窦房结折返(1例)。有5名女性和13名男性,年龄范围为8至81岁。14例心房扑动患者中有10例存在结构性心脏病,4例房内折返性心动过速患者曾接受先天性心脏病手术。13例典型心房扑动病例中有12例(92%)以及6例其他房性折返性快速心律失常(包括窦房结折返和5例与先天性心脏病手术相关的心律失常)中的6例获得了急性成功。1例患者发生了深静脉血栓形成。射频导管消融通过切断缓慢传导的狭窄通道,可以安全地消除人类的折返性房性心律失常。由于这些患者通常患有心房疾病,消融的心律失常可能复发或出现新的心律失常,因此需要进行长期随访评估。